Financial Wire

Truist表示，戰爭餘波和春季銷售淡季或將拖累房屋建築商的盈利。

-- Truist Securities週四表示，受中東衝突帶來的經濟影響，幾家美國主要房屋建築商今年的盈利可能受到衝擊，本已疲軟的春季銷售季更是雪上加霜。 這家券商下調了六家房屋建築商下一季和全年的獲利預期。這六家公司分別是D.R. Horton (DHI)、Meritage Homes (MTH)、NVR (NVR)、PulteGroup (PHM)、Taylor Morrison Homes (TMHC)和Toll Brothers (TOL)。 Truist也下調了這六家公司的目標股價，因為通膨以及受2月底爆發的美以戰爭影響，油價上漲導致消費者信心下降。 Truist分析師Jonathan Bettenhausen在給客戶的報告中表示：“這場戰爭的時機非常不巧。” “儘管我們認為業內對今年春季銷售季的預期已經表明，銷售額將比去年同期下降個位數百分比左右，但我們認為地緣政治環境的顯著惡化不太可能被納入這些預期之中。” 該券商表示，雖然他們預計其覆蓋的股票中“不會有很多股票業績超出預期”，但他們最看好的是泰勒·莫里森（Taylor Morrison），該股在最新季度財報發布前的表現尤為突出。貝滕豪森寫道，這隻股票可能「已經消化了最多的壞消息」。 這位分析師表示：“我們認為，人們對春季銷售季的樂觀情緒已經基本消散，因此我們相應地下調了（上半年）以及下半年的需求預期，因為春季（按訂單生產）新訂單需求預計會下降。” 由於3月份的新房銷售和新住宅建設數據尚未公佈，抵押貸款報告和谷歌趨勢等其他市場指標“並未顯示出令人鼓舞的需求趨勢，我們認為，這證實了當前市場對需求的普遍看法。” 週三，全美住宅建築商協會和富國銀行表示，受經濟不確定性、建材成本上漲和利率上升的影響，美國住宅建築商信心指數本月跌至9月以來的最低點。 白宮對與伊朗達成協議持樂觀態度，並指出第二輪談判可能在巴基斯坦舉行。上週末，美伊和平談判在伊斯蘭堡結束，但未達成協議。同時，華盛頓和德黑蘭之間為期兩週的停火協議仍然有效。

Price: $144.72, Change: $+0.52, Percent Change: +0.36%

Related Articles

Australia

Sector Update: Financial Stocks Softer Late Afternoon

Financial stocks fell in late Thursday afternoon trading with the NYSE Financial Index and the State Street Financial Select Sector SPDR ETF (XLF) each easing 0.2%.The Philadelphia Housing Index dropped 0.5%, and the State Street Real Estate Select Sector SPDR ETF (XLRE) rose 0.8%.Bitcoin (BTC-USD) gained 0.4% to $75,140, and the yield for 10-year US Treasuries advanced 2.7 basis points to 4.309%.In economic news, US initial jobless claims last week fell to 207,000 from a downwardly revised 218,000 in the previous week, compared with expectations for a smaller decrease to 213,000 in a survey of analysts by Bloomberg.US industrial production fell by 0.5% in March, compared with expectations for a 0.1% increase in a Bloomberg survey, and following an upwardly revised 0.7% increase in February.The Philadelphia Federal Reserve's monthly manufacturing index rose to 26.7 in April after increasing to 18.1 in March, compared with expectations for a decline to 10 in a survey compiled by Bloomberg.The New York Federal Reserve's services index improved to minus 14 in April from minus 22.6 in March, compared with minus 20 expected in a survey compiled by Bloomberg.In regulatory news, the US Securities and Exchange Commission is seeking public comment in support of a comprehensive review of the Consolidated Audit Trail and other such audit trails used in the regulation of the country's securities markets.In corporate news, Charles Schwab's (SCHW) Q1 results rose amid a surge in client assets, even as revenue fell short of Wall Street's estimates. The shares fell 7.7%.Goldman Sachs (GS) rates-trading business faced pressure in Q1 as Iran-related market volatility led to losses on certain positions, Reuters reported. The bank posted a 10% drop in fixed-income, currencies and commodities revenue to $4 billion, driven by weaker results in interest-rate trading, mortgages, and credit products, the report said. Goldman shares were little changed.Marsh & McLennan (MRSH) shares climbed 4.6% after the company reported Q1 adjusted net income and revenue that surpassed analysts' estimates.The National Basketball Association is in early discussions with private credit firms, including Apollo Global Management (APO), Ares Management (ARES) and Sixth Street about funding a potential European basketball league expansion, Bloomberg reported. Apollo shares rose 0.1%, and Ares fell 2.7%.

$APO$ARES$GS$MRSH$SCHW
Japan

US Equity Indexes Advance After Trump Announces Israel-Lebanon Ceasefire Deal

US equity indexes rose ahead of Thursday's close after Israel and Lebanon agreed to a 10-day ceasefire, removing a major obstacle to the Middle East diplomacy for a lasting Iran truce deal.The Nasdaq Composite rose 0.2% to 24,069.1, with the S&P 500 up 0.2% to 7,035.2, and the Dow Jones Industrial Average higher by 0.2% to 48,583.5. Energy, real estate, and technology led the gainers. Health care was the worst performer.President Trump said the US might hold discussions with Iran this weekend, The Wall Street Journal reported. "We're very close to making a deal," the president told reporters outside the White House, according to the WSJ. Trump said he wasn't sure the current two-week ceasefire in the war would need to be extended, according to the report.Earlier on Thursday, Trump said on Truth Social that Lebanon and Israel have agreed to a 10-day ceasefire starting 5 pm ET. Lebanese Prime Minister Nawaf Salam said he welcomed the decision. In a follow-up social media post on Thursday, Trump said he will invite the Lebanese President, Joseph Aoun, and Israel's Prime Minister Benjamin Netanyahu to the White House for talks.Meanwhile, US Defense Secretary Pete Hegseth said Thursday that the naval blockade of Iran is an example of "polite" behavior during the ongoing ceasefire, and US forces are ready to strike power plants and the energy industry in the country, if ordered, according to a report from Reuters.West Texas Intermediate crude oil futures rose 2.5% to $93.77, and Brent crude futures jumped 3.7% to $98.58.

$^DJI$^IXIC$^SPX
Sectors

Sector Update: Health Care Stocks Decline Late Afternoon

Health care stocks were softer late Thursday afternoon, with the NYSE Health Care Index and the State Street Health Care Select Sector SPDR ETF (XLV) each decreasing 0.7%.The iShares Biotechnology ETF (IBB) dropped 1.3%.In corporate news, Abbott Laboratories (ABT) lowered its full-year earnings outlook on Thursday to reflect the acquisition of cancer diagnostics company Exact Sciences, while the healthcare firm reported Q1 results above market estimates. Its shares fell past 5%.Gilead Sciences (GILD) could beat Q1 consensus estimates, but weaker-than-expected persistence rates for Yeztugo point to a potential risk to long-term peak sales for the HIV pre-exposure prophylaxis drug, RBC Capital Markets said in a note. Gilead shares were down 0.8%.QuidelOrtho (QDEL) shares tumbled 28%. The company said late Wednesday it expects preliminary unaudited revenue of $615 million to $620 million for Q1. Analysts polled by FactSet expect $677.8 million.Hims & Hers Health (HIMS) shares jumped past 12% after a senior US health official signaled plans to ease restrictions on certain peptides.

$ABT$GILD$HIMS$QDEL